Abstract:Glutamatergic neurotransmission and oxidative stress are involved in the pathophysiology of seizures. Some anticonvulsants exert their effects through modulation of these pathways. Trigonelline (TRG) has been shown to possess various pharmacological effects like neuroprotection. Therefore, this study was performed to determine TRG's anticonvulsant effects, focusing on its potential effects on N-methyl-D-aspartate (NMDA) receptors, a type of glutamate receptor, and oxidative stress state in the prefrontal cortex (PFC) in PTZ-induced seizure in mice. Seventy-two male mice were randomly divided into nine groups. The groups included mice that received normal saline, TRG at doses of 10, 50, and 100 mg/kg, diazepam, NMDA (an agonist), ketamine (an antagonist), the effective dose of TRG with NMDA, as well as sub-effective dose of TRG with ketamine, respectively. All agents were administrated intraperitoneally 60 min before induction of seizures by PTZ. Latency to seizure, total antioxidant capacity (TAC), and malondialdehyde (MDA) levels in serum and PFC were measured. Furthermore, the gene expression of NR2A and NR2B, subunits of NMDA receptors, was measured in the PFC. TRG administration increased the latency to seizure onset and enhanced TAC while reducing MDA levels in both the PFC and serum. TRG also decreased the gene expression of NR2B in the PFC. Unexpectedly, the findings revealed that the concurrent administration of ketamine amplified, whereas NMDA mitigated, the impact of TRG on latency to seizure. Furthermore, NMDA diminished the positive effects of TRG on antioxidant capacity and oxidative stress, while ketamine amplified these beneficial effects, indicating a complex interaction between TRG and NMDA receptor modulation. In the gene expression of NMDA receptors, results showed that ketamine significantly decreased the gene expression of NR2B when co-administrated with a sub-effective dose of TRG. It was found that, at least partially, the anticonvulsant effect of TRG in PTZ-induced seizures in male mice was mediated by the attenuation of glutamatergic neurotransmission as well as the reduction of oxidative stress.

Cholestane-3β, 5α, 6β-triol suppresses neuronal hyperexcitability via binding to voltage-gated sodium channels

Cholesterol Metabolite Cholestane-3Β,5α,6β-triol Suppresses Epileptic Seizures by Negative Modulation of Voltage-Gated Sodium Channels

Cholesterol Metabolite Cholestane-3 Beta,5 Alpha,6 Beta-Triol Suppresses Epileptic Seizures By Negative Modulation Of Voltage-Gated Sodium Channels

The Major Cholesterol Metabolite Cholestane-3Β,5α,6β-triol Functions As an Endogenous Neuroprotectant.

Cholestane-3β,5α,6β-Triol Inhibits Acid-Sensing Ion Channels and Reduces Acidosis-Mediated Ischemic Brain Injury

Characterization of a Synthetic Steroid 24‐keto‐cholest‐5‐en‐3β, 19‐diol As a Neuroprotectant

Neuroprotectant Androst-3Β, 5α, 6Β-Triol Suppresses TNF-α-induced Endothelial Adhesion Molecules Expression and Neutrophil Adhesion to Endothelial Cells by Attenuation of CYLD-NF-κB Pathway.

Tuning Sodium Channel Blockers to the Near-Atomic Level

Dual-pocket Inhibition of Navchannels by the Antiepileptic Drug Lamotrigine

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

TRIOL Inhibits Rapid Intracellular Acidification and Cerebral Ischemic Injury: the Role of Glutamate in Neuronal Metabolic Reprogramming

Voltage-gated sodium channels, potential targets of Tripterygium wilfordii Hook. f. to exert activity and produce toxicity

Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo

Trigonelline as an anticonvulsant agent: mechanistic insights into NMDA receptor expression and oxidative stress balance

Triolein alleviates ischemic stroke brain injury by regulating autophagy and inflammation through the AKT/mTOR signaling pathway

Effects of the Calcium Channel Blocker Otilonium Bromide on Seizure Activity in Rats With Pentylenetetrazole-Induced Convulsions

Modulation of Kv7 Channel Currents by Echinocystic Acid

Naturally Occurring Marine Steroid 24-Methylenecholestane-3β,5α,6β,19-tetraol Functions As a Novel Neuroprotectant.

Discovery of triazenyl triazoles as Na<sub>v</sub>1.1 channel blockers for treatment of epilepsy

Molecular Mechanism of a Specific NLRP3 Inhibitor to Alleviate Seizure Severity Induced by Pentylenetetrazole

TRESK channel contributes to depolarization-induced shunting inhibition and modulates epileptic seizures